Targeting Anti-Inflammatory Pathways to Treat Diabetes-Induced Neuropathy by 6-Hydroxyflavanone
Nutrients · 2023
DOI: 10.3390/nu15112552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Shehla Akbar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, CECOS University of IT and Emerging Sciences, Peshawar 25000, Pakistan. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Neuralgia, Diabetes Mellitus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
It is evident that inflammation and metabolic syndrome instigated by diabetes mellitus can precipitate diabetes-induced neuropathy (DIN) and pain. In order to find an effective therapeutic method for diabetes-related problems, a multi-target-directed ligand model was used. 6-Hydroxyflavanone (6-HF) carrying anti-inflammatory and anti-neuropathic pain potential due to its quadruplicate mechanisms, targeting cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX), and opioid and GABA-A receptors was investigated. The anti-inflammatory potential of the test drug was confirmed utilizing in silico, in vitro, and in vivo tests. A molecular simulation approach was utilized to observe the interaction of 6-HF with the inflammatory enzyme COX-2 as well as opioid and GABA-A receptors. The same was confirmed via in vitro COX-2 and 5-LOX inhibitory assays. In vivo tests were performed to analyze the thermal anti-nociception in the hot-plate analgesiometer and anti-inflammatory action in the carrageenan-induced paw edema model in rodents. The potential anti-nociceptive effect of 6-HF was evaluated in the DIN model in rats. The Naloxone and Pentylenetetrazole (PTZ) antagonists were used to confirm the underlying mechanism of 6-HF. The molecular modeling studies revealed a favorable interaction of 6-HF with the identified protein molecules. In vitro inhibitory studies revealed that 6-HF inhibited the COX-2 and 5-LOX enzymes significantly. The 6-HF at dosages of 15, 30, and 60 mg/kg substantially reduced heat nociception in a hot plate analgesiometer as well as carrageenan-induced paw edema in rodent models. The authors discovered that 6-HF had anti-nociception properties in a streptozotocin-induced diabetic neuropathy model. According to the findings of this study, 6-HF was demonstrated to diminish inflammation caused by diabetes as well as its anti-nociception effect in DIN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, CECOS University of IT and Emerging Sciences, Peshawar 25000, Pakistan.
- North West Institute of Health Sciences, Peshawar 25000, Pakistan.
- Institute of Basic Medical Sciences, Khyber Medical University, Peshawar 25000, Pakistan.
- Department of Pharmacy, Sarhad University of Science and Technology, Peshawar 25000, Pakistan.
- Department of Biochemistry, Shankar Abdul Wali Khan University, Mardan 23200, Pakistan.
ORCID-Profile: Saad Salman
Zitieren
APA
Akbar, S., Subhan, F., Akbar, A., Habib, F., Shahbaz, N., Ahmad, A., Wadood, A., & Salman, S. (2023). Targeting Anti-Inflammatory Pathways to Treat Diabetes-Induced Neuropathy by 6-Hydroxyflavanone. Nutrients. https://doi.org/10.3390/nu15112552
Vancouver
Akbar S, Subhan F, Akbar A, Habib F, Shahbaz N, Ahmad A, et al. Targeting Anti-Inflammatory Pathways to Treat Diabetes-Induced Neuropathy by 6-Hydroxyflavanone. Nutrients. 2023. doi:10.3390/nu15112552
BibTeX
@article{Akbar2023,
author = {Akbar, Shehla and Subhan, Fazal and Akbar, Aroosha and Habib, Faiza and Shahbaz, Naila and Ahmad, Ashfaq and Wadood, Abdul and Salman, Saad},
title = {Targeting Anti-Inflammatory Pathways to Treat Diabetes-Induced Neuropathy by 6-Hydroxyflavanone},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15112552}
}
EUVIMED